{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:43:48Z","timestamp":1705430628729},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jhep.2010.10.017","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:40:58Z","timestamp":1291113658000},"page":"11-18","source":"Crossref","is-referenced-by-count":9,"title":["ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo"],"prefix":"10.1016","volume":"55","author":[{"given":"Hiromi","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukiko","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Nelson","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chise","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Yoshizato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsuhira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.10.017_b0005","unstructured":"WHO: Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35\u201347."},{"key":"10.1016\/j.jhep.2010.10.017_b0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus","volume":"12","author":"Kiyosawa","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0015","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/hep.510280632","article-title":"Prognosis of chronic hepatitis C: results of a large, prospective cohort study","volume":"28","author":"Niederau","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.10.017_b0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.10.017_b0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.10.017_b0035","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1016\/j.bmc.2005.04.074","article-title":"Preventive effects of soyasapogenol B derivatives on liver injury in a concanavalin A-induced hepatitis model","volume":"13","author":"Sasaki","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jhep.2010.10.017_b0040","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/eji.200323651","article-title":"ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism","volume":"33","author":"Klein","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2010.10.017_b0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejphar.2006.05.003","article-title":"Protective effects of alpha1-acid glycoprotein and serum amyloid A on concanavalin A-induced liver failure via interleukin-6 induction by ME3738","volume":"541","author":"Kuzuhara","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2010.10.017_b0050","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1111\/j.1530-0277.2006.00286.x","article-title":"Effect of the inducer of interleukin-6 (ME3738) on rat liver treated with ethanol","volume":"31","author":"Fukumura","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2010.10.017_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2007.07.004","article-title":"ME3738 protects against lithocholic acid-induced hepatotoxicity, which is associated with enhancement of biliary bile acid and cholesterol output","volume":"574","author":"Nomoto","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2010.10.017_b0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1872-034X.2008.00326.x","article-title":"Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats","volume":"38","author":"Maeda","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2010.10.017_b0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.22289","article-title":"Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta","volume":"48","author":"Hiasa","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.1840190505","article-title":"Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection","volume":"19","author":"Tsubota","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.10.017_b0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2010.10.017_b0085","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.febslet.2007.04.021","article-title":"Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon","volume":"581","author":"Hiraga","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2010.10.017_b0090","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.21209","article-title":"Anti-HCV therapies in chimeric acid-Alb\/uPA mice parallel outcomes in human clinical application","volume":"43","author":"Kneteman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0095","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1099\/vir.0.83658-0","article-title":"Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice","volume":"89","author":"Kimura","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2010.10.017_b0100","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbrc.2005.02.138","article-title":"Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system","volume":"329","author":"Ikeda","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.10.017_b0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jhep.2010.10.017_b0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1099\/vir.0.82319-0","article-title":"Dual effect of APOBEC3G on Hepatitis B virus","volume":"88","author":"Noguchi","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2010.10.017_b0115","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/JCM.37.6.1802-1808.1999","article-title":"Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen","volume":"37","author":"Aoyagi","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2010.10.017_b0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jhep.2002.34130","article-title":"Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication","volume":"36","author":"Bouvier-Alias","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.017_b0125","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.77.2.1092-1104.2003","article-title":"Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons","volume":"77","author":"Lanford","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2010.10.017_b0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1165\/rcmb.2007-0287OC","article-title":"IL-6 cytoprotection in hyperoxic acute lung injury occurs via suppressor of cytokine signaling-1 induced apoptosis signal-regulating kinase-1 degradation","volume":"40","author":"Kolliputi","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jhep.2010.10.017_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbrc.2007.07.052","article-title":"The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells","volume":"361","author":"Xu","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.10.017_b0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbrc.2006.07.016","article-title":"IL-6 protects enterocytes from hypoxia-induced apoptosis by induction of bcl-2 mRNA and reduction of fas mRNA","volume":"347","author":"Rollwagen","year":"2006","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810010779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810010779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T05:42:10Z","timestamp":1592113330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810010779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0168827810010779"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.10.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}